We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

129 hedge funds and large institutions have $628M invested in Arena Pharmaceuticals Inc in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 44 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less capital invested

Capital invested by funds: $645M → $628M (-$16.9M)

10% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 21

2% less funds holding

Funds holding: 131 → 129 (-2)

25% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 44

47% less call options, than puts

Call options by funds: $22.8M | Put options by funds: $43.1M

Holders
129
Holders Change
-2
Holders Change %
-1.53%
% of All Funds
3.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
33
Reduced
44
Closed
21
Calls
$22.8M
Puts
$43.1M
Net Calls
-$20.2M
Net Calls Change
+$4.67M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$19.9M
2
Norges Bank
Norges Bank
Norway
+$13.7M
3
Morgan Stanley
Morgan Stanley
New York
+$8.89M
4
Group One Trading
Group One Trading
Illinois
+$4.34M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.6M

Top Sellers

Rank Fund Capital Flow
1
BA
BlackRock Advisors
Delaware
-$6.18M
2
BFA
BlackRock Fund Advisors
California
-$4.12M
3
Goldman Sachs
Goldman Sachs
New York
-$3.68M
4
State Street
State Street
Massachusetts
-$3.57M
5
Bank of America
Bank of America
North Carolina
-$3.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
51
AQR Capital Management
Connecticut
$725K – – –
SM
52
Sabby Management
Florida
$690K -$616K -9,788 -45%
Citadel Advisors
53
Citadel Advisors
Florida
$558K +$53.5K +849 +10%
Canada Pension Plan Investment Board
54
Canada Pension Plan Investment Board
Ontario, Canada
$546K +$587K +9,320 New
BG
55
BlackRock Group
United Kingdom
$530K -$835K -13,266 -59%
UBS AM
56
UBS AM
Illinois
$493K – – –
SCM
57
Stevens Capital Management
Pennsylvania
$471K +$320K +5,089 +172%
LPL Financial
58
LPL Financial
California
$460K -$46.9K -745 -9%
Millennium Management
59
Millennium Management
New York
$447K -$81.3K -1,291 -14%
NPC
60
National Planning Corporation
California
$436K -$1.57K -25 -0.3%
Janney Montgomery Scott
61
Janney Montgomery Scott
Pennsylvania
$417K – – –
PP
62
PDT Partners
New York
$396K -$383K -6,080 -47%
Cambridge Investment Research Advisors
63
Cambridge Investment Research Advisors
Iowa
$394K – – –
CC
64
Callan Capital
California
$387K +$416K +6,612 New
T. Rowe Price Associates
65
T. Rowe Price Associates
Maryland
$367K +$44.1K +700 +13%
Fidelity Investments
66
Fidelity Investments
Massachusetts
$348K – – –
Renaissance Technologies
67
Renaissance Technologies
New York
$336K +$361K +5,736 New
LWM
68
Lyons Wealth Management
Florida
$334K – – –
Prudential Financial
69
Prudential Financial
New Jersey
$325K +$172K +2,729 +97%
Wells Fargo
70
Wells Fargo
California
$321K +$132K +2,090 +61%
PAM
71
Paradigm Asset Management
New York
$302K +$324K +5,150 New
Bank of America
72
Bank of America
North Carolina
$288K -$3.21M -50,900 -91%
AG
73
Aperio Group
California
$285K -$12K -190 -4%
Principal Financial Group
74
Principal Financial Group
Iowa
$268K -$158K -2,509 -35%
HK
75
Horizon Kinetics
New York
$264K – – –
1 2
3
4 5

ARNA Hedge Fund Activity: Q2 2014 in Review

129 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2014, worth a combined $628M — down 2.6% from $645M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ARNA and 19 opened new positions — a net loss of 2 holders — while 44 trimmed existing stakes and 33 added.

The largest buyer was Deerfield Management, adding an estimated $19.9M. The largest seller was BlackRock Advisors, cutting an estimated $6.18M.

  • 129 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2014, down from 131 in Q1 2014.
  • Funds reported $628M of Arena Pharmaceuticals Inc stock for Q2 2014, down 2.6% quarter-over-quarter.
  • 19 funds opened new Arena Pharmaceuticals Inc positions in Q2 2014 and 21 closed out, a net change of -2 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2014 was Deerfield Management, an estimated $19.9M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2014 was BlackRock Advisors, an estimated $6.18M sold.

Based on aggregated 13F filings for Q2 2014.